Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab As First-Line Treatment of Metastatic Renal Cell Carcinoma (mrcc) in a Subpopulation of Elderly and Poor Performance Status Patients
Cancers(2025)
Key words
metastatic renal cell carcinoma,ipilimumab and nivolumab,elderly,poor performance status,low KPS,efficacy,toxicity,real-world evidence
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined